Borut Štrukelj was born in Ljubljana, in 1961. He is a full professor at the Department for Pharmaceutical Biology at the Faculty of Pharmacy, Ljubljana where he leads the group for Pharmaceutical Biotechnology. At the Jozef Stefan Institute, he is a member of the biotechnology group. By using post-doc EMBO award, he worked at the CPRO-DLO, PRI Institute for plant molecular biology in Wageningen, Netherlands. Prof. Štrukelj published a great number of over 180 scientific and proffesional articles, among them over 140 in the important international scientific journals. He is a member of many Slovene and international pharmaceutical and biomedicinal associations. In year 1991 he was awarded for his scientific contribution in the field of molecular biology by Kidirič award. In year 2007 he got a national award for his excellent scientific contribution (Zois award) an in year 2015 the most prominenent Zois top award. From year 1996 till 2012 he was appointed as an expert in European Pharmacopoea in a Group for biological pharmaceuticals as well as at the European Agency for Medicines in London (EMEA). In year 2010 he received the Fulbright Award for visiting professorship at the Duquesne University, Pittsburgh, USA. His research is focused on biological medicines, recombinant probiotics, phage display technology and plant secondary metabolites. In the last four years, he was appointed by the Consortium for Drug addiction Slovenia to run the group dealing with the regulatory issues of medicinal cannabis, presenting the regulatory status of medicinal cannabis at several conferences in Slovenia and Austira.